medigraphic.com
ENGLISH

Cirugía y Cirujanos

  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2019, Número 5

<< Anterior Siguiente >>

Cir Cir 2019; 87 (5)


La disfagia de corta evolución y su asociación con la esofagitis disecante y enfermedades concurrentes. Un reto diagnóstico

Teramoto-Matsubara, Óscar; Galvis-García, Elymir S; Abdo-Francis, Juan M; Sobrino-Cossío, Sergio; Orozco-Gamiz, Antonio; Morales-Arámbula, Miguel; Carrasco-Rojas, J Antonio; Meza-Caballero, Marisi
Texto completo Cómo citar este artículo Artículos similares

Idioma: Español
Referencias bibliográficas: 45
Paginas: 572-579
Archivo PDF: 530.58 Kb.


PALABRAS CLAVE

Candidiasis esofágica, Disfagia, Esofagitis disecante, Esofagitis eosinofílica.

RESUMEN

La esofagitis disecante (ESD) es una enfermedad rara que puede asociarse a esofagitis eosinofílica, candidiásica o medicamentos. Se analizaron las características clinico-endoscópicas e histopatológicas en sujetos con disfagia de corta evolución asociada a afecciones concurrentes. Estudio observacional de cohorte retrospectiva con disfagia y daño mucoso. Se ingresaron 23 pacientes con edad media de 55 años. Todos tuvieron síntomas de reflujo gastroesofágico (ERGE), disfagia y odinofagia. Fueron 10, 9 y 4 casos de ESD, descamativa/esfacelante (ESD/ES) y fibroestenosis, respectivamente. La ESD/SE es una afección rara, con un espectro clínico, endoscópico e histológico variable.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Blevins CH, Iyer PG, Vela MF, Katzka DA. The esophageal epithelial barrier in health and disease. Clin Gastroenterol Hepatol. 2018;16:608-17.

  2. Jiménez P, Lanas A, Piazuelo E, et al. Effect of growth factors and prostaglandin E2 on restitution and proliferation of rabbit esophageal epithelial cells. Dig Dis Sci. 1998;43:2309-16.

  3. Jiménez P, Lanas A, Piazuelo E, et al. Effects of extracellular pH on restitution and proliferation of rabbit oesophageal epithelial cells. Aliment Pharmacol Ther. 1999;13 545-52.

  4. Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci. 2012;1258:9-18.

  5. Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776-84

  6. Honda J, Iijima K, Asanuma K, et al. Estrogen enhances esophageal barrier function by potentiating occludin expression. Dig Dis Sci. 2016;61:1028-38.

  7. Álvaro-Villegas JC, Sobrino-Cossío S, Hernández-Guerrero A, et al. Dilated intercellular spaces in subtypes of gastroesophagic reflux disease. Rev Esp Enferm Dig. 2010;102:302-7.

  8. Green A, Streutker CJ. Esophagitis: old histologic concepts and new thoughts. Arch Pathol Lab Med. 2015;139:723-9.

  9. Krugmann J, Neumann H, Vieth M, Armstrong D. What is the role of endoscopy and oesophageal biopsies in the management of GERD? Best Pract Res Clin Gastroenterol. 2013;27:373-85.

  10. Fiocca R, Mastracci L, Riddell R, et al. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol. 2010;41:223-31.

  11. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108 679-92.

  12. Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43:297-316.

  13. Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19:90-6.

  14. Gentile N, Katzka D, Ravi K, Trenkner S, Enders F, Killian J, et al. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014;40:1333-40.

  15. Lee J, Huprich J, Kujath C, et al. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012;10:481-6.

  16. Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140:82-90.

  17. Moawad FJ, Robinson CL, Veerappan GR, Summers TA, Maydonovitch CL, Wong RKH. The tug sign: an endoscopic feature of eosinophilic esophagitis. Am J Gastroenterol. 2013;108:1938-9.

  18. Chehade M, Sampson HA, Morotti RA, Magid MS. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:319-28.

  19. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.

  20. Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43:201-18.

  21. Tutuian R. Adverse effects of drugs on the esophagus. Best Pract Res Clin Gastroenterol. 2010;24:91-7.

  22. De Petris G, Gatius Caldero S, Chen L, et al. Histopathological changes in the gastrointestinal tract due to drugs: an update for the surgical pathologist (part I of II). Int J Surg Pathol. 2014;22:120-8.

  23. Wilcox CM, Schwartz DA. Endoscopic-pathologic correlates of Candida esophagitis in acquired immunodeficiency syndrome. Dig Dis Sci. 1996;41:1337-45.

  24. Maguire A, Sheahan K. Pathology of oesophagitis. Histopathology. 2012;60:864-79.

  25. Almashat SJ, Duan L, Goldsmith JD. Non-reflux esophagitis: a review of inflammatory diseases of the esophagus exclusive of reflux esophagitis. Sem Diagn Path. 2014;31:89-99.

  26. Hart PA, Romano RC, Moreira RK, Ravi K, Sweetser S. Esophagitis dissecans superficialis: clinical, endoscopic, and histologic features. Dig Dis Sci. 2015;60:2049-57.

  27. Carmack SW, Vemulapalli R, Spechler SJ, Genta RM. Esophagitis dissecans superficialis (“sloughing esophagitis”): a clinicopathologic study of 12 cases. Am J Surg Pathol. 2009;33:1789-94.

  28. Purdy JK, Appelman HD, McKenna BJ. Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa. Mod Pathol. 2012;25:767-75.

  29. Ma Ch, et al. Recently highlighted non-neoplastic pathologic entities of their upper GI tract and their clinical significance. Gastrointest Endosc. 2014;80:960-5.

  30. Rosenberg B. Oesophagitis dissecans superficialis. Centralbl Allg Pathol u Path Anat. 1892;3:753-9.

  31. Chen WC, et al. Desquamative esophagitis: a refractory mucosal injury pattern. Dis Esophagus. 2017;30:1-5.

  32. Abbass K, Haveman L, Gertner E. Esophagitis dissecans superficialis due to severe methotrexate toxicity. Endoscopy. 2014;46(Suppl 1): E99-100.

  33. Cameron RB. Esophagitis dissecans superficialis and alendronate: case report. Gastrointest Endosc. 1997;46:562-3.

  34. Hokama A, Ihama Y, Nakamoto M, Kinjo N, Kinjo F, Fujita J. Esophagitis dissecans superficiales associated with bisphosphonates. Endoscopy. 2007;39(Suppl 1):E91.

  35. De Petris G, Gatius Caldero S, et al. Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II). Int J Surg Pathol. 2013;22:202-11.

  36. Pérez-Carreras M, Castellano G, Colina F, et al. Esophagitis dissecans superficialis (esophageal cast) complicating esophageal sclerotherapy. Am J Gastroenterol. 1998;93 655-6.

  37. Hokama A, Yamamoto Y, Taira K, et al. Esophagits dissecans superficialis and autoimmune bullous dermatoses: a review. World J Gastrointest Endosc. 2010;2:252-6.

  38. Shih A, Misdraji J. Drug-induced pathology of the upper gastrointestinal tract. Diagnostic Histopathology. 2017;23:84-95.

  39. Zografos GN, Georgiadou D, Thomas D, et al. Drug-induced esophagitis. Dis Esophagus. 2009;22:633e7.

  40. Zehou O, Raynaud JJ, Roux-Villet L, Alexandre M, Airinei G, Pascal F, et al. Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid. Br J Dermatol. 2017;177:1074-85.

  41. Hage-Nassar G, Rotterdam H, Frank D, et al. Esophagitis dissecans superficialis associated with celiac disease. Gastrointest Endosc. 2003; 57:140-1.

  42. Morgenstern M. Tube-like expulsion of esophageal mucosa (esophagitis exfoliativasive dissecans superficialis). Zentralbl Allg Pathol 1952;89: 17-22.

  43. Kurian A, Haber R. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature. J Cutan Med Surg. 2011;15:275-9.

  44. Albert DM, Ally MR, Moawad FJ. The sloughing esophagus: a report of five cases. Am J Gastroenterol. 2013;108(11), 1816-7.

  45. Brandt L. Esophagitis dissecans superficialis. Gastrointest Endosc. 2011; 74:403-4.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Cir. 2019;87

ARTíCULOS SIMILARES

CARGANDO ...